Chondrex
Chondrex is a privately held Woodinville, Washington-based reagent supplier specializing in purified collagens, monoclonal antibodies, ELISA kits, and adjuvants for arthritis, inflammation, allergy, and nephritis research, serving academic labs, pharmaceutical R&D, and CROs globally through direct e-commerce and distributors.
- Company typePrivate
- Founded1996
- HeadquartersWoodinville, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Chondrex does
Chondrex, Inc. is a privately held, specialized life-science reagent supplier founded in 1996 and headquartered in Woodinville, Washington, operating with a 1–10 person team. The company focuses on the biochemistry and immunology of collagen and collagen-related materials, providing highly purified collagens (types I, II, III, IV, V, IX, XI across more than ten species), monoclonal antibodies, ELISA assay kits, adjuvants (Complete/Incomplete Freund's Adjuvant and Muramyl Dipeptide), and complete reagent sets for in-vivo disease models including Collagen-Induced Arthritis (CIA), Collagen Antibody-Induced Arthritis (CAIA), DSS-Colitis, and nephritis. Differentiating capabilities include proprietary purification methods (repetitive salt precipitation and DEAE-cellulose chromatography) that produce low-antigenicity collagen preparations offered in multiple grades (immunization, cell culture, ELISA, T-cell assay), and a growing catalog of application-specific protocols and kits in allergy (e.g., peanut Ara h 1/2, Alternaria Alt a 1), NETs, and paracellular permeability research.
Chondrex monetizes primarily through one-time direct purchases of reagents via its e-commerce storefront (chondrex.com) at unit prices ranging from approximately $18 to $3,770, with quote-based bulk pricing available. Distribution combines direct online sales with a network of international distributors enabling global reach. The customer base is horizontally segmented: the primary segment is academic and institutional life-science researchers studying arthritis, inflammation, allergy, connective tissue disease, and nephritis, with a secondary segment of pharmaceutical, biotech, and contract research organizations using the reagents for preclinical drug discovery.
The company has invested recently in product-line extension rather than scale expansion: 2026 launches include lyophilized FITC-labeled bovine Type II collagen, recombinant Alternaria allergen, peanut-allergen IgE ELISA kits, immunization-grade Type III collagen, and three new application protocols. No funding rounds, acquisitions, leadership changes, or AI/ML capabilities are disclosed, and revenue is not publicly reported. Strategic posture is that of an entrenched, specialist reagent supplier extending its catalog and protocol footprint steadily rather than scaling headcount or pursuing capital-funded expansion.
Chondrex firmographics
Firmographics- Name
- Chondrex
- Legal name
- Chondrex, Inc.
- Website
- https://chondrex.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Chondrex is a privately held Woodinville, Washington-based reagent supplier specializing in purified collagens, monoclonal antibodies, ELISA kits, and adjuvants for arthritis, inflammation, allergy, and nephritis research, serving academic labs, pharmaceutical R&D, and CROs globally through direct e-commerce and distributors.
- Ownership category
- akta.pro rank
Chondrex industry classification
Industry- Product category
- Life Science Research Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Chondrex is headquartered
LocationHeadquarters
- HQ city
- Woodinville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Chondrex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Research Reagent Sales: Chondrex generates revenue through the sale of high-quality research reagents including collagen products, monoclonal antibodies, assay kits, adjuvants, and related biochemicals. Products are sold directly via their e-commerce platform with pricing ranging from approximately $18 to $3,770 per unit depending on the product type and quantity. Bulk quantities are available at discounted prices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Immunization Grade Collagen - Unit pricing per mg |
| Unit Pricing | Pay-as-you-go | NETs Research Assay Kits and Antibodies |
| Unit Pricing | Pay-as-you-go | Adjuvants for Animal Studies |
| Unit Pricing | Pay-as-you-go | Collagen for CIA Model |
| Other | Pay-as-you-go | Quote-based pricing for bulk/custom orders |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Chondrex product offering
Product offeringCore offering
Chondrex manufactures and sells highly purified collagen reagents (Types I, II, III, IV, V, IX, XI from multiple species), monoclonal antibodies, ELISA assay kits, adjuvants, and complete reagent sets for arthritis, inflammation, allergy, connective tissue, and nephritis research. Its products support academic researchers, pharmaceutical/biotech firms, and contract research organizations performing animal disease models (CIA, CAIA, DSS-colitis, nephritis) and biomarker detection assays.
Product overview
Chondrex is a specialized reagent company offering high-quality products for arthritis and inflammation research. The company provides a comprehensive portfolio of collagen products (including types I, II, III, IV, V, IX, and XI from multiple species), monoclonal antibodies, ELISA assay kits, adjuvants (Complete/Incomplete Freund's Adjuvant, MDP), and complete reagent sets for animal disease models including Collagen-Induced Arthritis (CIA), CAIA, DSS-Colitis, and nephritis models. The product line also includes NETs (Neutrophil Extracellular Traps) research kits, fungal allergen products, and immunoassay buffers. Products are available in multiple grades (immunization, cell culture, ELISA, T-cell assay) to accommodate various research needs.
Differentiator
Problem solved
Functional benefit
Companies that use Chondrex
Customer profileSegments2 records
Ideal customer profiles2 records
Chondrex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Chondrex partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- International DistributorscoreChondrex maintains a network of international distributors to serve researchers globally outside the United States. These distributors enable local sales, shipping, and customer support for the company's research reagent products in international markets.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Chondrex competitors and assessment
Company assessmentBroad incumbents
- Abcam: Abcam is a global antibody and reagent supplier with broad coverage of research applications including collagen and inflammation-related targets, competing with Chondrex for life science research dollars.
- Bio-Techne (R&D Systems): Bio-Techne owns R&D Systems and Novus Biologicals, offering an extensive catalog of antibodies, ELISA kits, and proteins including collagen-related reagents that overlap with Chondrex's portfolio.
- MilliporeSigma (Sigma-Aldrich): MilliporeSigma supplies collagen types, biochemicals, and immunological reagents used in arthritis and inflammation research, representing a major incumbent competing with Chondrex on catalog breadth.
- Cell Signaling Technology: Cell Signaling Technology produces high-quality antibodies and ELISA kits used in inflammation and immunology research, representing a larger incumbent with overlapping antibody and assay offerings.
- Thermo Fisher Scientific: Thermo Fisher Scientific (including Invitrogen, Gibco, and Thermo Scientific brands) is the largest life science tools company, offering collagen, antibodies, ELISA kits, and adjuvants that compete broadly with Chondrex's catalog.
Direct peers
- Cayman Chemical: Cayman Chemical is a biochemical reagent supplier offering ELISA kits, antibodies, and assay reagents for inflammation and immunology research, competing with Chondrex in similar academic and CRO customer segments.
- MD Bioproducts: MD Bioproducts specializes in collagen-induced arthritis (CIA) and collagen antibody-induced arthritis (CAIA) reagents, monoclonal antibodies, and ELISA kits for inflammatory disease research, directly overlapping Chondrex's flagship product lines.
- Santa Cruz Biotechnology: Santa Cruz Biotechnology offers a broad portfolio of antibodies and research reagents including collagen-related products, competing directly with Chondrex for academic and preclinical research customers.
- Enzo Life Sciences: Enzo Life Sciences provides biochemical and immunological assay kits, antibodies, and reagents for inflammation and autoimmune disease research, with overlap to Chondrex's ELISA and assay kit offerings.
- Hooke Laboratories: Hooke Laboratories provides CIA and CAIA model kits, collagen antibodies, and arthritis research reagents that compete head-to-head with Chondrex in academic and pharma preclinical research markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Chondrex social profiles
Digital presenceChondrex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chondrex leadership team
Management profileNumber of profiles
Chondrex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chondrex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chondrex
What does Chondrex do?
Chondrex manufactures and sells highly purified collagen reagents (Types I, II, III, IV, V, IX, XI from multiple species), monoclonal antibodies, ELISA assay kits, adjuvants, and complete reagent sets for arthritis, inflammation, allergy, connective tissue, and nephritis research. Its products support academic researchers, pharmaceutical/biotech firms, and contract research organizations performing animal disease models (CIA, CAIA, DSS-colitis, nephritis) and biomarker detection assays.
Is Chondrex a public or private company?
Chondrex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Chondrex founded?
Chondrex was founded in 1996. It employs 1 to 10 people.
Where is Chondrex based?
Chondrex is headquartered in Woodinville, United States, in the North America region.
How does Chondrex make money?
One revenue line is on record: research Reagent Sales.
Who are Chondrex's main competitors?
Broad incumbents on record are Abcam, Bio-Techne (R&D Systems), MilliporeSigma (Sigma-Aldrich), Cell Signaling Technology and Thermo Fisher Scientific. Direct peers are Cayman Chemical, MD Bioproducts, Santa Cruz Biotechnology, Enzo Life Sciences and Hooke Laboratories.
Does Chondrex have an API?
No public API is recorded for Chondrex.
What industry is Chondrex in?
Chondrex's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.